Invesco’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$39.7M Buy
4,140,072
+489,260
+13% +$4.69M 0.01% 1153
2025
Q1
$22.9M Sell
3,650,812
-20,574
-0.6% -$129K ﹤0.01% 1369
2024
Q4
$29.8M Sell
3,671,386
-425,376
-10% -$3.45M 0.01% 1296
2024
Q3
$74.1M Buy
4,096,762
+953,310
+30% +$17.2M 0.01% 890
2024
Q2
$32.4M Sell
3,143,452
-16,337
-0.5% -$168K 0.01% 1202
2024
Q1
$33.6M Sell
3,159,789
-7,864
-0.2% -$83.5K 0.01% 1211
2023
Q4
$28.9M Sell
3,167,653
-251,306
-7% -$2.29M 0.01% 1237
2023
Q3
$35.5M Buy
3,418,959
+86,822
+3% +$900K 0.01% 1096
2023
Q2
$47.7M Buy
3,332,137
+1,150,465
+53% +$16.5M 0.01% 965
2023
Q1
$15.6M Sell
2,181,672
-25,977
-1% -$185K ﹤0.01% 1480
2022
Q4
$24.8M Buy
2,207,649
+139,781
+7% +$1.57M 0.01% 1270
2022
Q3
$22.9M Buy
2,067,868
+21,062
+1% +$233K 0.01% 1239
2022
Q2
$17.3M Sell
2,046,806
-2,953
-0.1% -$24.9K 0.01% 1463
2022
Q1
$27.9M Sell
2,049,759
-17,597
-0.9% -$239K 0.01% 1287
2021
Q4
$40.7M Buy
2,067,356
+71,340
+4% +$1.4M 0.01% 1138
2021
Q3
$64.1M Sell
1,996,016
-25,384
-1% -$815K 0.02% 956
2021
Q2
$68.4M Sell
2,021,400
-7,531
-0.4% -$255K 0.02% 954
2021
Q1
$76.2M Sell
2,028,931
-25,507
-1% -$958K 0.02% 903
2020
Q4
$68.2M Sell
2,054,438
-25,749
-1% -$855K 0.02% 915
2020
Q3
$76.3M Sell
2,080,187
-15,256
-0.7% -$559K 0.03% 746
2020
Q2
$69M Buy
2,095,443
+19,758
+1% +$650K 0.02% 765
2020
Q1
$53.6M Sell
2,075,685
-26,618
-1% -$687K 0.02% 767
2019
Q4
$65.5M Buy
+2,102,303
New +$65.5M 0.02% 874